“…Late-stage CIE, akin to more common and facile hydrogen isotope exchange (HIE), allows for the streamlined production of the labeled compounds, and has become an emerging concept and an active area of research. 14 The pioneering methods from Gauthier, 15 Baran, 16 and Cantat/Audisio 17 using 13 CO or 13 CO2, to facilitate CIE showed the power of utilizing transition metal catalysts to achieve C-C bond activation, allowing for a sustainable late-stage carbon isotope enrichment strategy for pharmaceutically relevant small molecules. Despite added progress in this arena [18][19][20][21][22] , CIE labeling approaches are limited to carboxylic acids, revealing the unmet need for new CIE methods to address the diverse functional groups present in pharmaceuticals and natural products, and ideally employing easily handleable solid labeling sources (Figure 2A).…”